Clinical Trial Update: Long Protocol and Growth Hormone in Poor Responders [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating long protocol with growth hormone in poor responders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Woman's Health University Hospital, Egypt | Conditions: Infertility | Phase 2 | Status: COMPLETED